Suppr超能文献

[甲状腺与心脏:病理生理背景、诊断及治疗影响]

[Thyroid gland and the heart : Pathophysiological background, diagnostic and therapeutic consequences].

作者信息

Dischinger U, Fassnacht M

机构信息

Medizinische Klinik und Poliklinik I, Schwerpunkt Endokrinologie und Diabetologie, Universitätsklinikum Würzburg, Oberdürrbacher Str. 6, 97070, Würzburg, Deutschland.

出版信息

Internist (Berl). 2018 Jul;59(7):668-673. doi: 10.1007/s00108-018-0441-2.

Abstract

BACKGROUND

Irregularities in thyroid-specific laboratory parameters are frequent in the general population. Observational studies have shown associations between dysfunction of the thyroid gland and cardiovascular morbidity and mortality.

OBJECTIVE

The aim of this review is to give a critical overview of the relationship and treatment recommendations for the simultaneous occurrence of functional disorders of the thyroid gland and the heart.

MATERIAL AND METHODS

Literature searches were conducted in PubMed and Medline.

RESULTS AND CONCLUSION

Overt and also to a lesser extent subclinical hyperthyroidism are of relevance for cardiovascular mortality and morbidity, even though interventional studies are missing. Therefore, basic thyroid diagnostics are recommended when cardiovascular diseases occur or deteriorate. Whereas overt hyperthyroidism and hypothyroidism are treated immediately, subclinical thyroid dysfunction disorders require confirmation by laboratory testing. In cases with confirmed subclinical hyperthyroidism and heart disease, a thyroid-specific treatment is meaningful (e. g. with radioiodine). At what point a subclinical hypothyroidism should be treated is controversial. We usually initiate substitution treatment with levothyroxine only in patients with a thyroid-stimulating hormone (TSH) level > 10 mIU/l. A control of baseline thyroid parameters is necessary prior to initiation of any treatment with amiodarone or with deterioration of the general condition.

摘要

背景

甲状腺特异性实验室参数异常在普通人群中很常见。观察性研究表明甲状腺功能障碍与心血管发病率和死亡率之间存在关联。

目的

本综述旨在对甲状腺功能障碍与心脏功能障碍同时出现的关系及治疗建议进行批判性概述。

材料与方法

在PubMed和Medline上进行文献检索。

结果与结论

尽管缺乏干预性研究,但显性以及程度较轻的亚临床甲状腺功能亢进与心血管死亡率和发病率相关。因此,当心血管疾病发生或恶化时,建议进行基本的甲状腺诊断。显性甲状腺功能亢进和甲状腺功能减退需立即治疗,而亚临床甲状腺功能障碍则需要通过实验室检测来确诊。对于确诊为亚临床甲状腺功能亢进且患有心脏病的患者,进行甲状腺特异性治疗是有意义的(例如使用放射性碘)。亚临床甲状腺功能减退应在何时治疗存在争议。我们通常仅在促甲状腺激素(TSH)水平>10 mIU/l的患者中开始使用左甲状腺素进行替代治疗。在开始使用胺碘酮治疗或全身状况恶化之前,有必要对基线甲状腺参数进行监测。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验